198 related articles for article (PubMed ID: 376141)
1. Report of the Committee on Pathology of Cutaneous T Cell Lymphomas.
Clendenning WE; Rappaport HW
Cancer Treat Rep; 1979 Apr; 63(4):719-24. PubMed ID: 376141
[No Abstract] [Full Text] [Related]
2. Ultrastructural appearance of cutaneous T cell lymphomas in skin, lymph nodes, and peripheral blood.
Guccion JG; Fischmann AB; Bunn PA; Schechter GP; Patterson RH; Matthews MJ
Cancer Treat Rep; 1979 Apr; 63(4):565-70. PubMed ID: 312693
[No Abstract] [Full Text] [Related]
3. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas.
Bunn PA; Lamberg SI
Cancer Treat Rep; 1979 Apr; 63(4):725-8. PubMed ID: 445521
[No Abstract] [Full Text] [Related]
4. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy.
Schechter GP; Bunn PA; Fischmann AB; Matthews MJ; Guccion J; Soehnlen F; Munson D; Minna JD
Cancer Treat Rep; 1979 Apr; 63(4):571-4. PubMed ID: 312694
[TBL] [Abstract][Full Text] [Related]
5. Serum IL-31 levels are increased in patients with cutaneous T-cell lymphoma.
Ohmatsu H; Sugaya M; Suga H; Morimura S; Miyagaki T; Kai H; Kagami S; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2012 May; 92(3):282-3. PubMed ID: 22456907
[No Abstract] [Full Text] [Related]
6. Clinical features of cutaneous T-cell lymphoma.
Abel EA
Dermatol Clin; 1985 Oct; 3(4):647-64. PubMed ID: 2878755
[TBL] [Abstract][Full Text] [Related]
7. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
Safai B
Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
[No Abstract] [Full Text] [Related]
9. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
10. [Mycosis fungoides and Sézary syndrome. A retrospective study of 60 patients with correlation between histologic classification and survival time].
Hödl S
Z Hautkr; 1986 Jul; 61(14):993-1013. PubMed ID: 3751216
[TBL] [Abstract][Full Text] [Related]
11. Memorials and mandates for cutaneous lymphomas.
Heald PW
Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
[No Abstract] [Full Text] [Related]
12. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
13. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous T-cell lymphoma.
Lansigan F; Choi J; Foss FM
Hematol Oncol Clin North Am; 2008 Oct; 22(5):979-96, x. PubMed ID: 18954747
[TBL] [Abstract][Full Text] [Related]
15. [Lymph node histopathologic aspects in cutaneous lymphomas of the mycosis fungoides or Sézary syndrome type. Retrospective study of 98 biopsies].
Wechsler J; Diebold J; Gerard-Marchant R
Ann Pathol; 1987; 7(2):122-9. PubMed ID: 3620027
[TBL] [Abstract][Full Text] [Related]
16. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
Olsen EA; Whittaker S; Kim YH; Duvic M; Prince HM; Lessin SR; Wood GS; Willemze R; Demierre MF; Pimpinelli N; Bernengo MG; Ortiz-Romero PL; Bagot M; Estrach T; Guitart J; Knobler R; Sanches JA; Iwatsuki K; Sugaya M; Dummer R; Pittelkow M; Hoppe R; Parker S; Geskin L; Pinter-Brown L; Girardi M; Burg G; Ranki A; Vermeer M; Horwitz S; Heald P; Rosen S; Cerroni L; Dreno B; Vonderheid EC; ; ;
J Clin Oncol; 2011 Jun; 29(18):2598-607. PubMed ID: 21576639
[TBL] [Abstract][Full Text] [Related]
17. [Lymph node localization of epidermotropic T malignant lymphomas (mycosis fungoides and Sézary's syndrome)].
Wechsler J; Diebold J; Gérard-Marchant R
Bull Cancer; 1984; 71(2):89-99. PubMed ID: 6610451
[TBL] [Abstract][Full Text] [Related]
18. Serum-soluble herpes virus entry mediator levels reflect disease severity and Th2 environment in cutaneous T-cell lymphoma.
Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Acta Derm Venereol; 2013 Jul; 93(4):465-7. PubMed ID: 23306973
[No Abstract] [Full Text] [Related]
19. [Epidermotropic T lymphomas].
Sigal-Nahum M; Brousse N; Belaïch S
Rev Prat; 1987 May; 37(25):1423-31. PubMed ID: 3495856
[No Abstract] [Full Text] [Related]
20. Is bone marrow biopsy necessary in patients with mycosis fungoides and Sézary syndrome? A histological and molecular study at diagnosis and during follow-up.
Beylot-Barry M; Parrens M; Delaunay M; Thiebault R; Vergier B; DeMascarel A; Dubus P; Beylot C; Merlio JP
Br J Dermatol; 2005 Jun; 152(6):1378-9. PubMed ID: 15949023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
